Corrigendum: No causal association between plasma cystatin C and cardiovascular diseases: Mendelian randomization analyses in UK biobank

Jingjing Tu,Ying Xu,Xu Guo,Jiayu Zhang,Duo Xu,Liyuan Han,Yue Wang,Boya Zhang,Hongpeng Sun

DOI: https://doi.org/10.3389/fmed.2023.1361467

2024-01-08

Abstract:[This corrects the article DOI: 10.3389/fmed.2023.1191675.].

What problem does this paper attempt to address?

No causal association between plasma cystatin C and cardiovascular diseases: Mendelian randomization analyses in UK biobank

Jingjing Tu,Ying Xu,Xu Guo,Jiayu Zhang,Duo Xu,Liyuan Han,Yue Wang,Boya Zhang,Hongpeng Sun

DOI: https://doi.org/10.3389/fmed.2023.1191675

2023-08-17

Abstract:Background: We aimed to determine whether the plasma cystatin C is a causal risk factor for cardiovascular events, stroke, myocardial infarction (MI), and cardiovascular disease (CVD) mortality by conducting Mendelian randomization (MR) designs. Methods: Our study included 277,057 individuals free of CVDs or cancer at baseline in the UK Biobank. The genetic scores of plasma cystatin C comprising 67 single-nucleotide polymorphisms were calculated on the basis of data from a large genome-wide association study. By stratifying the genetic score, we conducted cox regression to assess the relationship between plasma cystatin C and CVDs. In this study, linear MR analysis was used to estimate the causal association between plasma cystatin C and CVDs. Results: Observational analyses showed that plasma cystatin C concentrations were associated with the risk of CVDs [hazard ratios (HR) per standard deviation (SD) 1.09, 95% confidence interval (CI); 1.07-1.10] and CVD mortality (1.14, 1.11-1.17). Among CVDs, plasma cystatin C were associated with stroke (1.10, 1.08-1.11) and MI (1.08, 1.07-1.10). Linear MR analysis did not provide evidence of a causal association between plasma cystatin C and the risk of CVDs [odds ratio (OR) per SD 0.96, 95% CI;0.90-1.03], stroke (0.96, 0.93-1.01), MI (0.97, 0.91-1.03), and CVD mortality (0.98, 0.96-1.01), with consistent estimates from sensitivity analyses. Conclusion: Observational findings indicated that higher plasma cystatin C is associated with a higher risk of CVDs; According to MR studies, there is no causal association between plasma cystatin C and the risk of CVDs and CVD mortality.
Corrigendum to "Plasma superoxide dismutase activity in relation to disability in activities of daily living and objective physical functioning among Chinese older adults" [Maturitas, Volume 161, July 2022, Pages 12-17].

Xueqin Li,Xingqi Cao,Zhimin Ying,Guangtao Yang,Emiel O Hoogendijk,Zuyun Liu

DOI: https://doi.org/10.1016/j.maturitas.2023.107850

IF: 5.11

2023-01-01

Maturitas

Abstract:The authors regret that the affiliation for authors Xueqin Li, Xingqi Cao and Zuyun Liu were incorrectly stated in the original publication. The full and correct affiliation is restated herein. The corresponding author's address is: The Second Affiliated Hospital, School of Public Health, Zhejiang University School of Medicine, 866 Yuhangtang Rd, Hangzhou, 310058, Zhejiang, China. The authors would like to apologise for any inconvenience caused. Plasma superoxide dismutase activity in relation to disability in activities of daily living and objective physical functioning among Chinese older adultsMaturitasVol. 161PreviewWith the rapid population aging and the advance in medical technologies, increasing numbers of older adults worldwide are living longer, but a part of them are living with high levels of disability [1]. Disability, defined as the need for personal assistance with daily activities essential for self-care and independent living [2], is associated with an increased risk of mortality [3]. Disability could be partially explained by age-related degenerations in skeletal muscle and is highly dynamic in later life [4,5]. Full-Text PDF
Correction: Aliskiren Therapy in Hypertension and Cardiovascular Disease: a Systematic Review and a Meta-Analysis

Shufang Fu,Xin Wen,Fei Han,Longwei Yin,Gaosi Xu

DOI: https://doi.org/10.18632/oncotarget.24255

2018-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.19382.].
Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.

Hangying Ying,Hongdi Yuan,Xiaomei Tang,Wenpu Guo,Ruhong Jiang,Chenyang Jiang

DOI: https://doi.org/10.3389/fcvm.2021.723626

IF: 3.6

2021-01-01

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2021.641062.].
Correction: Corrigendum: Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney disease

Liu, Bei,Chen, Song-Chang,Yang, Yan-Mei,Yan, Kai,Qian, Ye-Qing,Zhang, Jun-Yu,Hu, Yu-Ting,Dong, Min-Yue,Jin, Fan,Huang, He-Feng,Xu, Chen-Ming

DOI: https://doi.org/10.1038/srep21578

IF: 4.6

2016-01-01

Scientific Reports

Abstract:Scientific Reports 5: Article number: 17468; published online: 03 December 2015; updated: 23 February 2016 This Article contains typographical errors in Table 2. For Family No. 19, the cDNA change ‘c.8795_8796insA’ and protein change ‘p.His2932GlnfsX5’ were incorrectly given as ‘c.8495-8496insA’ and‘p.
Corrigendum: Systolic blood pressure as the mediator of the effect of early menarche on the risk of coronary artery disease: A Mendelian randomization study

Hsien Yu Fan,Yen-Tsung Huang,Yun-Yu Chen,Justin BOKAI HSU,Hung-Yuan Li,Ta-Chen Su,Hung-Ju Lin,Kuo-Liong Chien,Yang Ching Chen

DOI: https://doi.org/10.3389/fcvm.2023.1165387

IF: 3.6

2023-03-01

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2022.1023355.].

cardiac & cardiovascular systems
Corrigendum: Diseases of the musculoskeletal system and connective tissue and risk of breast cancer: mendelian randomization study in European and East Asian populations

Yue-chen Xu,Jian-xiong Wang,Yi-ran Chu,Han Qian,Hong-yan Wang,Fan Wang

DOI: https://doi.org/10.3389/fonc.2023.1254132

IF: 4.7

2023-07-28

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1170119.].

oncology
Corrigendum: Assessing the causal relationship between genetically determined inflammatory biomarkers and low back pain risk: a bidirectional two-sample Mendelian randomization study

Wenhan Li,Qunwen Lu,Junhui Qian,Yue Feng,Jian Luo,Caigui Luo,Wenshan He,Bing Dong,Huahui Liu,Zhongxing Liu,Chengguo Su

DOI: https://doi.org/10.3389/fimmu.2023.1327338

2023-11-14

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1174656.].
Correction to: Letter to the Editor on "Causal associations between prostate diseases, renal diseases, renal function, and erectile dysfunction risk: a 2-sample Mendelian randomization study"

DOI: https://doi.org/10.1093/sexmed/qfae069

2024-09-24

Abstract:[This corrects the article DOI: 10.1093/sexmed/qfae058.].
No Causal Association Between Plasma Homocysteine Levels and Atrial Fibrillation: A Mendelian Randomization Study

Xingang Sun,Yunlong Lu,Zhen Wang,Qiqi Wang,Liangrong Zheng

DOI: https://doi.org/10.1016/j.numecd.2020.10.012

2021-01-01

Abstract:Background and aims: Although several studies have shown an association between plasma homocysteine (Hcy) levels and atrial fibrillation (AF), the causality remains unclear. We undertook a Mendelian randomization (MR) study to investigate the causal association between Hcy and AF. Methods and results: Single-nucleotide polymorphisms (SNPs) which genome-wide significantly associated with plasma Hcy levels were obtained from a genome-wide meta-analysis (N = 44 147). MR analyses including the random-effect inverse variance-weighted (IVW) meta-analysis, weighted median analysis, and MR-Egger regression were used to estimate the associations between the selected SNPs and AF based on a meta-analysis of genome-wide association study for AF (N = 588 190). The MR analyses revealed no causal role of genetically elevated plasma Hcy levels with AF risk (random-effect IVW, odds ratio per 1 SD increase in Hcy levels = 0.972, 95% confidence interval = 0.919 to 1.027, P = 0.308). The results were consistent with the weighted median method, MR-Egger and the analysis after excluding the pleiotropic SNPs. No heterogeneity and directional pleiotropy were observed in sensitivity analyses. Conclusion: The findings suggested that plasma Hcy levels were not causally associated with AF. (C) 2020 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V.
Circulating alpha-Klotho Levels in Relation to Cardiovascular Diseases: A Mendelian Randomization Study

Xingang Sun,Lu Chen,Yuxian He,Liangrong Zheng

DOI: https://doi.org/10.3389/fendo.2022.842846

IF: 6.055

2022-01-01

Frontiers in Endocrinology

Abstract:Background: Several studies have reported a protective role of circulating alpha-Klotho on cardiovascular diseases (CVD); however, the causality remains unclear. We aim to elucidate whether genetically predicted circulating alpha-Klotho levels were causally associated with the risk of coronary artery disease (CAD), atrial fibrillation (AF), heart failure (HF), stroke, ischemic stroke (IS), and IS subtypes. Methods: A two-sample Mendelian randomization (MR) study was designed, with 5 single-nucleotide polymorphisms associated with circulating alpha-Klotho levels utilized as instrumental variables. MR estimates on each CVD outcome derived from the fixed-effects inverse-variance weighted (IVW) approach in different data sources were combined by the fixed-effects meta-analysis approach, complemented by several sensitivity analyses including the simple median, the weighed median, MR-Egger regression, and MR-pleiotropy residual sum and outlier. Results: In the meta-analysis combining different data sources, suggestive inverse causal association of circulating alpha-Klotho concentrations with CAD [Odds ratio (OR), 0.97; 95% confidence interval (CI), 0.94, 1.00; P = 0.044] and significant inverse association of circulating alpha-Klotho concentrations with AF (OR, 0.96; 95% CI, 0.93, 0.99; P = 0.005) was observed. However, there was no causal association of alpha-Klotho with HF, any stroke, IS, or IS subtypes neither in different data sources nor in the meta-analysis. Complementary sensitivity analyses showed consistent and robust results in general. Conclusion: Evidence was found for a protective effect of circulating alpha-Klotho on the prevention of AF risk. However, no significant causal association between genetically predicted circulating alpha-Klotho levels and risk of CAD, HF, stroke, IS, or IS subtypes was found.
Corrigendum: Reduced serum calcium is associated with a higher risk of retinopathy in non-diabetic individuals: The Chinese Multi-provincial Cohort Study

Jiangtao Li,Dong Zhao,Qiuju Deng,Yongchen Hao,Miao Wang,Jiayi Sun,Jun Liu,Guandi Ren,Huiqi Li,Yue Qi,Jing Liu

DOI: https://doi.org/10.3389/fendo.2022.1114158

IF: 6.055

2022-12-21

Frontiers in Endocrinology

Abstract:[This corrects the article DOI: 10.3389/fendo.2022.973078.].

endocrinology & metabolism
Correction to: Changes in frailty and incident cardiovascular disease in three prospective cohorts

DOI: https://doi.org/10.1093/eurheartj/ehae175

IF: 39.3

2024-03-30

European Heart Journal

Abstract:This is a correction to: Di He, Zhaoping Wang, Jun Li, Kaixin Yu, Yusa He, Xinyue He, Yuanjiao Liu, Yuhao Li, Ruiyi Fu, Dan Zhou, Yimin Zhu, Changes in frailty and incident cardiovascular disease in three prospective cohorts, European Heart Journal , 2024; https://doi.org/10.1093/eurheartj/ehad885

cardiac & cardiovascular systems
Corrigendum: Integrated Genetics and Micronutrient Data to Inform the Causal Association Between Serum Calcium Levels and Ischemic Stroke

Qiang Meng,Lu Huang,Kai Tao,Yong Liu,Jiangpeng Jing,Wen Wang,Huaizhou Qin,Dayun Feng,Qing Cai

DOI: https://doi.org/10.3389/fcell.2020.634957

IF: 5.5

2020-12-18

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2020.590903.].

cell biology,developmental biology
Corrigendum: Functional variant rs12614 in CFB confers a low risk of IgA nephropathy by attenuating complement alternative pathway activation in Han Chinese

Dian-Chun Shi,Shao-Zhen Feng,Zhong Zhong,Lu Cai,Meng Wang,Dong-Ying Fu,Xue-Qing Yu,Ming Li

DOI: https://doi.org/10.3389/fimmu.2022.1098003

IF: 7.3

2022-11-24

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.973169.].

immunology
Correction to: Biomarkers in clinical epidemiology studies

DOI: https://doi.org/10.1093/ckj/sfae293

2024-09-28

Abstract:[This corrects the article DOI: 10.1093/ckj/sfae130.].
Corrigendum: The Protective Effects of Lipid-Lowering Agents on Cardiovascular Disease and Mortality in Maintenance Dialysis Patients: Propensity Score Analysis of a Population-Based Cohort Study

Ming-Hsien Tsai,Mingchih Chen,Yen-Chun Huang,Hung-Hsiang Liou,Yu-Wei Fang

DOI: https://doi.org/10.3389/fphar.2022.894462

IF: 5.6

2022-03-31

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2019.00079.].

pharmacology & pharmacy
Corrigendum to “Cd36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy”

Jing Zhao,Hongliang Rui,Min Yang,Lijun Sun,Hongrui Dong,Hong Cheng

DOI: https://doi.org/10.1155/2019/8247280

2019-01-01

Mediators of Inflammation

Abstract:In the article titled "CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy" [1], there were some input errors in Table 3 as the unit of kidney weight "mg," Lee's index "g/cm," and urinary protein "mg/d" are wrong and should be corrected as kidney weight "g," Lee's index "g 1/3 /cm," and urinary protein "μg/d."The corrected version of Table 3 is as follows:The authors apologize for these errors and confirm that they do not affect the conclusions or the results of this article.
Corrigendum: Evaluating the role of pericoronary adipose tissue on coronary artery disease: insights from CCTA on risk assessment, vascular stenosis, and plaque characteristics

Jingyue Wang,Huicong Zhang,Zihao Wang,Wenyun Liu,Dianbo Cao,Qian Tong

DOI: https://doi.org/10.3389/fcvm.2024.1531099

IF: 3.6

2024-12-03

Frontiers in Cardiovascular Medicine

Abstract:This article is a correction to: Evaluating the role of pericoronary adipose tissue on coronary artery disease: insights from CCTA on risk assessment, vascular stenosis, and plaque characteristics

cardiac & cardiovascular systems
Corrigendum: Blood Immune Cell Composition Associated With Obesity and Drug Repositioning Revealed by Epigenetic and Transcriptomic Conjoint Analysis

Jia-Chen Liu,Sheng-Hua Liu,Guang Fu,Xiao-Rui Qiu,Run-Dong Jiang,Sheng-Yuan Huang,Li-Yong Zhu,Wei-Zheng Li

DOI: https://doi.org/10.3389/fphar.2021.838902

IF: 5.6

2022-01-10

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.714643.].

pharmacology & pharmacy

Corrigendum: No causal association between plasma cystatin C and cardiovascular diseases: Mendelian randomization analyses in UK biobank

No causal association between plasma cystatin C and cardiovascular diseases: Mendelian randomization analyses in UK biobank

Corrigendum to "Plasma superoxide dismutase activity in relation to disability in activities of daily living and objective physical functioning among Chinese older adults" [Maturitas, Volume 161, July 2022, Pages 12-17].

Correction: Aliskiren Therapy in Hypertension and Cardiovascular Disease: a Systematic Review and a Meta-Analysis

Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.

Correction: Corrigendum: Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney disease

Corrigendum: Systolic blood pressure as the mediator of the effect of early menarche on the risk of coronary artery disease: A Mendelian randomization study

Corrigendum: Diseases of the musculoskeletal system and connective tissue and risk of breast cancer: mendelian randomization study in European and East Asian populations

Corrigendum: Assessing the causal relationship between genetically determined inflammatory biomarkers and low back pain risk: a bidirectional two-sample Mendelian randomization study

Correction to: Letter to the Editor on "Causal associations between prostate diseases, renal diseases, renal function, and erectile dysfunction risk: a 2-sample Mendelian randomization study"

No Causal Association Between Plasma Homocysteine Levels and Atrial Fibrillation: A Mendelian Randomization Study

Circulating alpha-Klotho Levels in Relation to Cardiovascular Diseases: A Mendelian Randomization Study

Corrigendum: Reduced serum calcium is associated with a higher risk of retinopathy in non-diabetic individuals: The Chinese Multi-provincial Cohort Study

Correction to: Changes in frailty and incident cardiovascular disease in three prospective cohorts

Corrigendum: Integrated Genetics and Micronutrient Data to Inform the Causal Association Between Serum Calcium Levels and Ischemic Stroke

Corrigendum: Functional variant rs12614 in CFB confers a low risk of IgA nephropathy by attenuating complement alternative pathway activation in Han Chinese

Correction to: Biomarkers in clinical epidemiology studies

Corrigendum: The Protective Effects of Lipid-Lowering Agents on Cardiovascular Disease and Mortality in Maintenance Dialysis Patients: Propensity Score Analysis of a Population-Based Cohort Study

Corrigendum to “Cd36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy”

Corrigendum: Evaluating the role of pericoronary adipose tissue on coronary artery disease: insights from CCTA on risk assessment, vascular stenosis, and plaque characteristics

Corrigendum: Blood Immune Cell Composition Associated With Obesity and Drug Repositioning Revealed by Epigenetic and Transcriptomic Conjoint Analysis